Type
. Educational material for the patient with leprosy. Leprosy review [Internet]. 1989;60(3):221-8. Available from: http://leprev.ilsl.br/pdfs/1989/v60n3/pdf/v60n3a08.pdf
Type
. [Syringomyelic form of leprosy]. Harefuah. 1989;117(3-4):66-8.
Type
. Blindness in leprosy--a forgotten complication. Australian and New Zealand journal of ophthalmology. 1989;17(3):257-60.
Type
. Leprosy. Australian and New Zealand journal of ophthalmology. 1989;17(3):211-3.
Type
. Changes in epidemiological indices following the introduction of WHO MDT into the Guyana leprosy control programme. Leprosy review [Internet]. 1989;60(2):151-6. Available from: http://leprev.ilsl.br/pdfs/1989/v60n2/pdf/v60n2a11.pdf
Type
. Will the leprosy endemic in Rwanda soon be under control?. Leprosy review [Internet]. 1989;60(2):139-46. Available from: http://leprev.ilsl.br/pdfs/1989/v60n2/pdf/v60n2a09.pdf
Type
. Management information system for leprosy eradication programme--an alternative information system. Leprosy review [Internet]. 1989;60(2):129-34. Available from: http://leprev.ilsl.br/pdfs/1989/v60n2/pdf/v60n2a07.pdf
Type
. Tumor necrosis factor in leprosy patients. The Journal of infectious diseases. 1989;159(4):787-90.
Type
. Immunogold labeling method for Mycobacterium leprae-specific phenolic glycolipid in glutaraldehyde-osmium-fixed and Araldite-embedded leprosy lesions. The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society [Internet]. 1989;37(4):455-62. Available from: http://jhc.sagepub.com/content/37/4/455.full.pdf+html
Type
. Effect of Mycobacterium leprae-infected Schwann cells and their supernatant on lymphocyte neuroglia interaction. Journal of neuroimmunology. 1989;22(2):149-55.